The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dengue Fever Treatment Market Research Report 2025
Synopsis
Global Dengue Fever Treatment market is projected to reach US$ 155.6 million in 2029, increasing from US$ 137 million in 2022, with the CAGR of 0.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dengue Fever Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dengue Fever Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Fresenius Kabi USA
Sun Pharmaceutical Industries
Mylan N.V
Pfizer
Teva Pharmaceuticals USA
EMERGEX VACCINES
Hikma Pharmaceuticals
ABIVAX, Aurobindo Pharma
Baxter
Perrigo
GlaxoSmithKline
Dr. Reddy’s Laboratories
Sanofi
Takeda Pharmaceutical
Segment by Type
Drug
Vaccines
Segment by Application
Hospital
Homecare
Specialty Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dengue Fever Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Dengue Fever Treatment market is projected to reach US$ 155.6 million in 2029, increasing from US$ 137 million in 2022, with the CAGR of 0.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dengue Fever Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dengue Fever Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Fresenius Kabi USA
Sun Pharmaceutical Industries
Mylan N.V
Pfizer
Teva Pharmaceuticals USA
EMERGEX VACCINES
Hikma Pharmaceuticals
ABIVAX, Aurobindo Pharma
Baxter
Perrigo
GlaxoSmithKline
Dr. Reddy’s Laboratories
Sanofi
Takeda Pharmaceutical
Segment by Type
Drug
Vaccines
Segment by Application
Hospital
Homecare
Specialty Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Dengue Fever Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Dengue Fever Treatment Market Overview
1.1 Product Overview and Scope of Dengue Fever Treatment
1.2 Dengue Fever Treatment Segment by Type
1.2.1 Global Dengue Fever Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Drug
1.2.3 Vaccines
1.3 Dengue Fever Treatment Segment by Application
1.3.1 Global Dengue Fever Treatment Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global Dengue Fever Treatment Market Size Estimates and Forecasts
1.4.1 Global Dengue Fever Treatment Revenue 2018-2029
1.4.2 Global Dengue Fever Treatment Sales 2018-2029
1.4.3 Global Dengue Fever Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dengue Fever Treatment Market Competition by Manufacturers
2.1 Global Dengue Fever Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dengue Fever Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dengue Fever Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Dengue Fever Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Dengue Fever Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dengue Fever Treatment, Product Type & Application
2.7 Dengue Fever Treatment Market Competitive Situation and Trends
2.7.1 Dengue Fever Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dengue Fever Treatment Players Market Share by Revenue
2.7.3 Global Dengue Fever Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dengue Fever Treatment Retrospective Market Scenario by Region
3.1 Global Dengue Fever Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dengue Fever Treatment Global Dengue Fever Treatment Sales by Region: 2018-2029
3.2.1 Global Dengue Fever Treatment Sales by Region: 2018-2023
3.2.2 Global Dengue Fever Treatment Sales by Region: 2024-2029
3.3 Global Dengue Fever Treatment Global Dengue Fever Treatment Revenue by Region: 2018-2029
3.3.1 Global Dengue Fever Treatment Revenue by Region: 2018-2023
3.3.2 Global Dengue Fever Treatment Revenue by Region: 2024-2029
3.4 North America Dengue Fever Treatment Market Facts & Figures by Country
3.4.1 North America Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dengue Fever Treatment Sales by Country (2018-2029)
3.4.3 North America Dengue Fever Treatment Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dengue Fever Treatment Market Facts & Figures by Country
3.5.1 Europe Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dengue Fever Treatment Sales by Country (2018-2029)
3.5.3 Europe Dengue Fever Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dengue Fever Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dengue Fever Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Dengue Fever Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dengue Fever Treatment Market Facts & Figures by Country
3.7.1 Latin America Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dengue Fever Treatment Sales by Country (2018-2029)
3.7.3 Latin America Dengue Fever Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dengue Fever Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Dengue Fever Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dengue Fever Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dengue Fever Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dengue Fever Treatment Sales by Type (2018-2029)
4.1.1 Global Dengue Fever Treatment Sales by Type (2018-2023)
4.1.2 Global Dengue Fever Treatment Sales by Type (2024-2029)
4.1.3 Global Dengue Fever Treatment Sales Market Share by Type (2018-2029)
4.2 Global Dengue Fever Treatment Revenue by Type (2018-2029)
4.2.1 Global Dengue Fever Treatment Revenue by Type (2018-2023)
4.2.2 Global Dengue Fever Treatment Revenue by Type (2024-2029)
4.2.3 Global Dengue Fever Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Dengue Fever Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dengue Fever Treatment Sales by Application (2018-2029)
5.1.1 Global Dengue Fever Treatment Sales by Application (2018-2023)
5.1.2 Global Dengue Fever Treatment Sales by Application (2024-2029)
5.1.3 Global Dengue Fever Treatment Sales Market Share by Application (2018-2029)
5.2 Global Dengue Fever Treatment Revenue by Application (2018-2029)
5.2.1 Global Dengue Fever Treatment Revenue by Application (2018-2023)
5.2.2 Global Dengue Fever Treatment Revenue by Application (2024-2029)
5.2.3 Global Dengue Fever Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Dengue Fever Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Fresenius Kabi USA
6.1.1 Fresenius Kabi USA Corporation Information
6.1.2 Fresenius Kabi USA Description and Business Overview
6.1.3 Fresenius Kabi USA Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Fresenius Kabi USA Dengue Fever Treatment Product Portfolio
6.1.5 Fresenius Kabi USA Recent Developments/Updates
6.2 Sun Pharmaceutical Industries
6.2.1 Sun Pharmaceutical Industries Corporation Information
6.2.2 Sun Pharmaceutical Industries Description and Business Overview
6.2.3 Sun Pharmaceutical Industries Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sun Pharmaceutical Industries Dengue Fever Treatment Product Portfolio
6.2.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.3 Mylan N.V
6.3.1 Mylan N.V Corporation Information
6.3.2 Mylan N.V Description and Business Overview
6.3.3 Mylan N.V Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Mylan N.V Dengue Fever Treatment Product Portfolio
6.3.5 Mylan N.V Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Dengue Fever Treatment Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Teva Pharmaceuticals USA
6.5.1 Teva Pharmaceuticals USA Corporation Information
6.5.2 Teva Pharmaceuticals USA Description and Business Overview
6.5.3 Teva Pharmaceuticals USA Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Pharmaceuticals USA Dengue Fever Treatment Product Portfolio
6.5.5 Teva Pharmaceuticals USA Recent Developments/Updates
6.6 EMERGEX VACCINES
6.6.1 EMERGEX VACCINES Corporation Information
6.6.2 EMERGEX VACCINES Description and Business Overview
6.6.3 EMERGEX VACCINES Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 EMERGEX VACCINES Dengue Fever Treatment Product Portfolio
6.6.5 EMERGEX VACCINES Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hikma Pharmaceuticals Dengue Fever Treatment Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 ABIVAX, Aurobindo Pharma
6.8.1 ABIVAX, Aurobindo Pharma Corporation Information
6.8.2 ABIVAX, Aurobindo Pharma Description and Business Overview
6.8.3 ABIVAX, Aurobindo Pharma Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ABIVAX, Aurobindo Pharma Dengue Fever Treatment Product Portfolio
6.8.5 ABIVAX, Aurobindo Pharma Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Baxter Dengue Fever Treatment Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 Perrigo
6.10.1 Perrigo Corporation Information
6.10.2 Perrigo Description and Business Overview
6.10.3 Perrigo Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Perrigo Dengue Fever Treatment Product Portfolio
6.10.5 Perrigo Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Dengue Fever Treatment Description and Business Overview
6.11.3 GlaxoSmithKline Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.11.4 GlaxoSmithKline Dengue Fever Treatment Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Dr. Reddy’s Laboratories
6.12.1 Dr. Reddy’s Laboratories Corporation Information
6.12.2 Dr. Reddy’s Laboratories Dengue Fever Treatment Description and Business Overview
6.12.3 Dr. Reddy’s Laboratories Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Dr. Reddy’s Laboratories Dengue Fever Treatment Product Portfolio
6.12.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Corporation Information
6.13.2 Sanofi Dengue Fever Treatment Description and Business Overview
6.13.3 Sanofi Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Sanofi Dengue Fever Treatment Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Takeda Pharmaceutical
6.14.1 Takeda Pharmaceutical Corporation Information
6.14.2 Takeda Pharmaceutical Dengue Fever Treatment Description and Business Overview
6.14.3 Takeda Pharmaceutical Dengue Fever Treatment Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Takeda Pharmaceutical Dengue Fever Treatment Product Portfolio
6.14.5 Takeda Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dengue Fever Treatment Industry Chain Analysis
7.2 Dengue Fever Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dengue Fever Treatment Production Mode & Process
7.4 Dengue Fever Treatment Sales and Marketing
7.4.1 Dengue Fever Treatment Sales Channels
7.4.2 Dengue Fever Treatment Distributors
7.5 Dengue Fever Treatment Customers
8 Dengue Fever Treatment Market Dynamics
8.1 Dengue Fever Treatment Industry Trends
8.2 Dengue Fever Treatment Market Drivers
8.3 Dengue Fever Treatment Market Challenges
8.4 Dengue Fever Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
